Hypertension Guidelines-JNC 8
320 likes | 2.25k Vues
This overview of the JNC 8 guidelines presents critical evidence-based recommendations for managing hypertension. With 1 in 3 patients affected, hypertension remains a leading risk factor for cardiovascular events. We'll discuss appropriate blood pressure targets, the role of antihypertensive medication, and specific considerations for demographic groups like diabetics and African-American patients. The guidelines emphasize the importance of personalized treatment plans, reassessment of medication regimens, and the integration of lifestyle changes to improve patient outcomes and reduce health risks.
Hypertension Guidelines-JNC 8
E N D
Presentation Transcript
Hypertension Guidelines-JNC 8 Vivek V. Sailam, MD Associated Cardiovascular Consultants Lourdes Cardiology
Disclosures No disclosures
Hypertension • Hypertension is the most common condition in primary care. • 1 in 3 patients have hypertension according to NHLBI • Risk factor for MI, CVA, ARF, death
Case • A 58 year old African-American woman with diabetes and dyslipidemia has a BP of 158/94 confirmed on several office visits. Other than obesity, the exam is normal. Labs show normal renal function, well-controlled lipids on atorvastatin and well-controlled diabetes on metformin. Urine micro-albumin is mildly elevated.
Case Question 1 • What goal BP is most appropriate for this patient? • <150/90 mmHg • <130/80 mmHg • <140/90 mmHg • <140/80 mmHg • <140/85 mmHg
JNC 8 • 2014 Evidence-Based Guidelines for the Management of High Blood Pressure in Adults • JAMA. 2014;311(5):507-520 • December 18, 2013
JNC 8: Hypertension ManagementQuestions Guiding Review • In adults with HTN: • Does initiating antihypertensive pharmacologic therapy at specific BP thresholds improve health outcomes? • Does treatment with antihypertensive pharmacologic therapy to a specified goal lead to improvements in health outcomes? • Do various antihypertensive drugs or drug classes differ in comparative benefits and harms on specific health outcomes?
JNC 8: Hypertension ManagementEvidence Review • Limited to RCT’s • Hypertensive adults > 18 years old • Sample size > 100 • Follow-up > 1 year • Reported effect of treatment on important health outcomes (mortality, MI, HF, CVA, ESRD) • January 1966 to December 2009 • Separate criteria used of RCT’s published after December 2009
JNC 8: Hypertension ManagementEvidence Review • RCT’s December 2009 – August 2013 • Major study in hypertension • ACCORD, NEJM 2010 • > 2,000 participants • Multicentered • Met all other inclusion/exclusion criteria
JNC 8: Graded Recommendations A – Strong evidence B – Moderate evidence C – Weak evidence D – Against E – Expert Opinion N – No recommendation
JNC 8: Drug TreatmentThresholds and Goals • Age > 60 yo • Systolic: • Threshold > 150 mmHg • Goal < 150 mmHg • LOE: Grade A • Diastolic: • Threshold > 90 mmHg • Goal < 90 mmHg • LOE: Grade A
JNC 8: Drug TreatmentThresholds and Goals • Age < 60 yo • Systolic: • Threshold > 140 mmHg • Goal < 140 mmHg • LOE: Grade E • Diastolic: • Threshold > 90 mmHg • Goal < 90 mmHg • LOE: Grade A for ages 40-59; Grade E for ages 18-39
JNC 8: Drug TreatmentThresholds and Goals • Age > 18 yo with CKD or DM • JNC 7: < 130/80 (MDRD NEJM 1994) • Systolic: • Threshold > 140 mmHg • Goal < 140 mmHg • LOE: Grade E • Diastolic: • Threshold > 90 mmHg • Goal < 90 mmHg • LOE: Grade E
JNC 8: Initial Drug Choice • Nonblack, including DM • Thiazide diuretic, CCB, ACEI, ARB • LOE: Grade B • Black, including DM • Thiazide diuretic, CCB • LOE: Grade B (Grade C for diabetics)
JNC 8: Initial Drug Choice • Age > 18 yo with CKD and HTN (regardless of race or diabetes) • Initial (or add-on) therapy should include an ACEI or ARB to improve kidney outcomes • LOE: Grade B • Blacks w/ or w/o proteinuria • ACEI or ARB as initial therapy (LOE: Grade E) • No evidence for RAS-blockers > 75 yo • Diuretic is an option for initial therapy
JNC 8: Subsequent Management • Reassess treatment monthly • Avoid ACEI/ARB combination • Consider 2-drug initial therapy for Stage 2 HTN (> 160/100) • Goal BP not reached with 3 drugs, use drugs from other classes • Consider referral to HTN specialist • LOE: Grade E
Dissenting Editorial • Ann Intern Med. January 14, 2014 • 5/17 authors (29%) • “Insufficient evidence” to increase target SBP to 150 mmHg. • Expertise vs. Scientific Evidence
Recent HTN Guideline Statements • 2013 ESH/ESC Guidelines for the management of arterial hypertension. • J Hypertnsion 2013;31:1281-1357. • An Effective Approach to High Blood Pressure Control: A Science Advisory From the AHA, ACC, and CDC. • Hypertension online November 15, 2013. • Clinical Practice Guidelines for the Management of HTN in the Community A Statements by the ASH/ISH. • J Hypertension 2014;32:3-15
Blood pressure goals in hypertensive patients SBP, systolic blood pressure; CV, cardiovascular; TIA, transient ischaemic attack; CHD, coronary heart disease; CKD, chronic kidney disease;DBP, diastolic blood pressure.
Hypertension treatment for people with diabetes SBP, systolic blood pressure; DBP, diastolic blood pressure; RAS, renin–angiotensin system.
Hypertension treatment for people with nephropathy SBP, systolic blood pressure; CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate; RAS, renin–angiotensin system.
Lifestyle changes for hypertensive patients * Unless contraindicated. BMI, body mass index.
Goal BP **KDIGO: <140/90 w/o albuminuria <130/80 if >30 mg/24hr *ADA: < 140/80 or lower
Thank you for your attention! vsailam@hotmail.com vs